文献速递神经肿瘤

TRIM37与EZH2相互作用通过Sonic Hedgehog通路表观遗传抑制PTCH1并调控胶质瘤干细胞的干性

TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway.
PubMed 文献 · J Neurooncol · 2024-06-17

本研究探讨TRIM37在胶质瘤干细胞(GSCs)中调控干性的机制。体外实验显示TRIM37在GSCs中表达高于配对非GSCs,敲低TRIM37促进凋亡、降低干性并减少裸鼠移植瘤生长。TRIM37与EZH2在核内共定位并相互作用,EZH2表观遗传下调PTCH1激活SHH通路,作者认为TRIM37可能是GBM的潜在治疗靶点。

要点

  • TRIM37在胶质瘤干细胞中表达高于配对非胶质瘤干细胞。
  • 敲低TRIM37促进GSCs凋亡、降低干性并减少裸鼠移植瘤生长。
  • TRIM37与EZH2相互作用,EZH2表观遗传下调PTCH1激活SHH通路。

核心结论

  • TRIM37通过与EZH2相互作用维持GSCs的细胞生长和干性。
  • EZH2通过下调SHH通路抑制因子PTCH1的表达来激活SHH干细胞信号通路。
  • 作者认为TRIM37可能是GBM的潜在治疗靶点。

研究设计与样本

  • 体外实验采用蛋白质印迹、RT-qPCR和免疫荧光检测基因表达,CCK-8检测细胞活力,流式细胞术检测细胞凋亡。
  • 采用免疫共沉淀(Co-IP)验证EZH2与TRIM37的相互作用,双荧光素酶报告基因实验和染色质免疫沉淀(ChIP)验证EZH2与PTCH1启动子的相互作用。
  • 体内实验采用原位植入胶质瘤小鼠模型验证肿瘤生长。

主要发现

  • TRIM37在GSCs中的表达高于配对非GSCs。
  • 敲低TRIM37促进GSCs凋亡、降低GSCs干性,并减少裸鼠GSCs移植瘤的肿瘤生长。
  • TRIM37与EZH2在细胞核内共定位并相互结合。
  • 敲低TRIM37或抑制EZH2均下调与Sonic Hedgehog(SHH)通路相关的蛋白表达。
  • EZH2表观遗传下调PTCH1,从而在GSCs中激活SHH通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioma stem cells (GSCs), which are known for their therapy resistance, play a substantial role in treatment inefficacy for glioblastoma multiforme (GBM). TRIM37, a member of the tripartite motif (TRIM) protein family initially linked to a rare growth disorder, has been recognized for its oncogenic role. However, the mechanism by which TRIM37 regulates tumor growth in glioma and GSCs is unclear. METHODS: For the in vitro experiments, gene expression was measured by western blotting, RT-qPCR, and immunofluorescence. Cell viability was detected by CCK-8, and cell apoptosis was detected by flow cytometry. The interaction between Enhancer of Zeste Homolog 2 (EZH2) and TRIM37 was verified by co-immunoprecipitation (Co-IP). The interaction between EZH2 and the PTCH1 promoter was verified using dual-luciferase reporter assay and chromatin immunoprecipitation (ChIP). For the in vivo experiments, an orthotopically implanted glioma mouse model was used to validate tumor growth. RESULTS: The expression of TRIM37 is higher in GSCs compared with matched non-GSCs. TRIM37 knockdown promotes apoptosis, decreased stemness in GSCs, and reduces tumor growth in GSCs xenografts of nude mice. TRIM37 and EZH2 co-localize in the nucleus and interact with each other. TRIM37 knockdown or EZH2 inhibition downregulates the protein expressions associated with the Sonic Hedgehog (SHH) pathway. EZH2 epigenetically downregulates PTCH1 to activate SHH pathway in GSCs. CONCLUSIONS: TRIM37 maintains the cell growth and stemness in GSCs through the interaction with EZH2. EZH2 activates SHH stem cell signaling pathway by downregulating the expression of SHH pathway suppressor PTCH1. Our findings suggest that TRIM37 may be a potential therapeutic target for GBM.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Cai L, Liu Y, Li Y, et al. TRIM37 interacts with EZH2 to epigenetically suppress PTCH1 and regulate stemness in glioma stem cells through sonic hedgehog pathway. J Neurooncol. 2024. PMID: 38884661. doi:10.1007/s11060-024-04726-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。